Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL

Y Kaneko et al. J Immunol. 1978 Aug.

. 1978 Aug;121(2):427-37.

No abstract available

Similar articles

Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
Toffaletti DL, Darrow TL, Scott DW. Toffaletti DL, et al. J Immunol. 1983 Jun;130(6):2982-6. J Immunol. 1983. PMID: 6189910
[Origin of effector and rosette-forming cells in transplantation immunity in mice].
Brondz BD, Kotomina IF. Brondz BD, et al. Biull Eksp Biol Med. 1973 Sep;76(9):69-72. Biull Eksp Biol Med. 1973. PMID: 4130411 Russian. No abstract available.
Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. I. Changes in reactivity with cytotoxic T lymphocytes and anti-H-2d sera.
Celis E, Hale AH, Russell JH, Eisen HN. Celis E, et al. J Immunol. 1979 Mar;122(3):954-8. J Immunol. 1979. PMID: 312828
Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation.
Lynch RG, Rohrer JW, Odermatt B, Gebel HM, Autry JR, Hoover RG. Lynch RG, et al. Immunol Rev. 1979;48:45-80. doi: 10.1111/j.1600-065x.1979.tb00298.x. Immunol Rev. 1979. PMID: 94898 Review. No abstract available.
Cellular immunogenetics and LD-CD collaboration.
Bach FH, Kuperman OJ, Sollinger HW, Zarling JM, Sondel PM, Alter BJ, Bach ML. Bach FH, et al. Transplant Proc. 1977 Mar;9(1):859-63. Transplant Proc. 1977. PMID: 68606 Review. No abstract available.